Riboflavin and Ultraviolet Light A Therapy as an Adjuvant Treatment for Medically Refractive Acanthamoeba Keratitis (Q85115619)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20884060%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20884060%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Riboflavin and Ultraviolet Light A Therapy as an Adjuvant Treatment for Medically Refractive Acanthamoeba Keratitis (English)

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

23 July 2024

main subject

Acanthamoeba keratitis

1 reference

1 reference

Suy Anne Martins

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20884060%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Sachin Kalyani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20884060%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Philip Stanley

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20884060%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

David Flikier

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20884060%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Ashley Behrens

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20884060%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Yasin A. Khan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20884060

23 July 2024

Renata T. Kashiwabuchi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20884060

23 July 2024

Juan M. Castro-Combs

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20884060

23 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20884060

23 July 2024

publication date

29 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20884060%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

14 February 2020

https://api.elsevier.com/content/article/PII:S016164201000713X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

https://api.elsevier.com/content/article/PII:S016164201000713X?httpAccept=text/plain

23 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

23 July 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20884060%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20884060%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20884060%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

324-331

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20884060%20AND%20SRC:MED&resulttype=core&format=json

Acanthamoeba keratitis successfully treated medically

14 February 2020

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine

23 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Results of a trial of combined propamidine isethionate and neomycin therapy for Acanthamoeba keratitis. Brolene Study Group

23 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity

23 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Complications of topical antimicrobial agents

23 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Perioperative treatment and prognostic factors for penetrating keratoplasty in Acanthamoeba keratitis unresponsive to medical treatment

23 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992.

23 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Trends in contact lens-related corneal ulcers.

23 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Molecular characterization of Acanthamoeba isolated from amebic keratitis related to orthokeratology lens overnight wear

23 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Six-year review of Acanthamoeba keratitis in New South Wales, Australia: 1997-2002.

23 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Tandem scanning confocal corneal microscopy in the diagnosis of suspected acanthamoeba keratitis

23 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Riboflavin/ultraviolet-a–induced collagen crosslinking for the treatment of keratoconus

23 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

A new treatment of keratectasia after LASIK by using collagen with riboflavin/UVA light cross-linking

23 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

[Irradiation of cornea with ultraviolet light and riboflavin administration as a new treatment for erosive corneal processes, preliminary results in four patients]

23 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Induction of Cross-links in Corneal Tissue

23 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

The use of riboflavin for the inactivation of pathogens in blood products

23 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Comparison of the DNA-damaging property of photosensitised riboflavin via singlet oxygen (1O2) and superoxide radical O2-. mechanisms.

23 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

In Vitro Studies of Effects of Light and Riboflavin on DNA and HeLa Cells

23 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light

23 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light.

23 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis

23 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Biomechanical evidence of the distribution of cross-links in corneas treated with riboflavin and ultraviolet A light

23 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis

23 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide

23 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy

23 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

The pathophysiology of Acanthamoeba keratitis

23 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Pathogenesis of Acanthamoeba infections

23 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Delay in diagnosis and outcome of Acanthamoeba keratitis

23 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Acanthamoeba keratitis: 2007: a train wreck in slow motion.

23 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Corneal toxicity of propamidine

23 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Progressive ulcerative keratitis related to the use of topical chlorhexidine gluconate (0.02%).

23 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Are cataract and iris atrophy toxic complications of medical treatment of acanthamoeba keratitis?

23 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Virulence and Resistance to Superoxide, Low pH and Hydrogen Peroxide among Strains of Mycobacterium tuberculosis

23 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Hydrogen peroxide damage to human corneal epithelial cells in vitro. Implications for contact lens disinfection systems

23 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Toxic effects of hydrogen peroxide on corneal endothelium

23 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Treatment of progressive keratoconus by riboflavin-UVA-induced cross-linking of corneal collagen: ultrastructural analysis by Heidelberg Retinal Tomograph II in vivo confocal microscopy in humans

23 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Keratocyte apoptosis after corneal collagen cross-linking using riboflavin/UVA treatment

23 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Endothelial cell damage after riboflavin–ultraviolet-A treatment in the rabbit

23 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

In vivo and in vitro collagenolytic activity of Acanthamoeba castellanii

23 July 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

Safety of corneal collagen cross-linking with UV-A and riboflavin in progressive keratoconus

23 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.OPHTHA.2010.06.041

23 July 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20884060%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference